Recombinant Human TROY/TNFRSF19 Fc Chimera Protein, CF
Recombinant Human TROY/TNFRSF19 Fc Chimera Protein, CF Summary
Product Specifications
Human TROY (Glu30-Leu170) Accession # AAF71828 |
DIEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus | |
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
1548-TR
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: TROY/TNFRSF19
TROY (also known as TAJ and TNFRSF19) is a 45‑55 kDa member of the TNF receptor superfamily of molecules (1‑4). It is widely expressed in the embryo, but shows limited expression in adult. In particular, embryonic
-
Hu, S. et al. (1999) Genomics 62:103.
-
Eby, M.T. et al. (2000) J. Biol. Chem. 275:15336.
-
Kojima, T. et al. (2000) J. Biol. Chem. 275:20742.
-
Hashimoto, T. et al. (2008) Cell Cycle 7:106.
-
Pispa, J. et al. (2003) Gene Exp. Patterns 3:675.
-
Mi, S. (2008) Cytokine Growth Factor Rev. 19:245.
-
Satoh, J. et al. (2007) Neuropathol. Appl. Neurobiol. 33:99.
-
Shao, Z. et al. (2005) Neuron 45:353.
-
Park, J.B. et al. (2000) Neuron 45:345.
-
Spanjaard, R.A. et al. (2007) Int. J. Cancer 120:1304.
-
Venkatesh, K. et al. (2007) J. Cell Biol. 177:393.
- Pispa, J. et al. (2008) Hum. Mol. Genet. 17:3380.
Citation for Recombinant Human TROY/TNFRSF19 Fc Chimera Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Authors: Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J
Nature, 2012-07-26;487(7408):505-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human TROY/TNFRSF19 Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human TROY/TNFRSF19 Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Human TROY/TNFRSF19 Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image